Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,056 | -8,671 | -3,820 | -19,127 | -13,281 |
| Depreciation Amortization | 86 | 58 | 29 | 822 | 628 |
| Accounts receivable | N/A | N/A | N/A | 34 | 6 |
| Accounts payable and accrued liabilities | 758 | 514 | 180 | -185 | -14 |
| Other Working Capital | 3,872 | 2,817 | 73 | 895 | 1,031 |
| Other Operating Activity | 301 | 211 | 780 | 3,596 | 3,410 |
| Operating Cash Flow | $-10,039 | $-5,071 | $-2,758 | $-13,965 | $-8,220 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,262 | N/A | N/A | N/A |
| PPE Investments | 300 | N/A | N/A | 204 | 211 |
| Purchase Of Investment | -1,661 | 8,713 | -720 | -22,535 | -1,611 |
| Sale Of Investment | 9,082 | N/A | 407 | 22,292 | 849 |
| Purchase Sale Intangibles | -96 | -76 | -33 | -592 | -444 |
| Other Investing Activity | -96 | -76 | -33 | -592 | -444 |
| Investing Cash Flow | $7,625 | $7,375 | $-346 | $-631 | $-995 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -122 | N/A |
| Debt Repayment | N/A | N/A | N/A | -4,732 | -4,854 |
| Common Stock Issued | 80 | 55 | N/A | 13,042 | 12,917 |
| Financing Cash Flow | $80 | $55 | $N/A | $8,188 | $8,063 |
| Beginning Cash Position | 32,093 | 32,093 | 32,093 | 38,501 | 38,501 |
| End Cash Position | 29,759 | 34,452 | 28,989 | 32,093 | 37,349 |
| Net Cash Flow | $-2,334 | $2,359 | $-3,104 | $-6,408 | $-1,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,039 | -5,071 | -2,758 | -13,965 | -8,220 |
| Capital Expenditure | 300 | N/A | N/A | -41 | -34 |
| Free Cash Flow | -9,739 | -5,071 | -2,758 | -14,006 | -8,254 |